From left: Mr. Sean Kirk, Founder & CEO of Rehouzd, and Mr. Ragul Shanmugam, Co-Founder & CTO of Rehouzd.
Dissecting protective versus detrimental immune responses uncovers biomarkers and mechanisms that can inform the rational design and evaluation of live attenuated vaccines against African swine fever ...